PIK3CA and breast cancer: These results confirm the hypothesis that PI3K inhibitors may potentiate cytotoxic activity of anti-microtubule agents in PIK3CA-mutated BC cell lines, as previously described (Badinloo and Esmaeili-Mahani, 2014[5]; Morgillo et al., 2017[34]; Rajput et al., 2019[37]).